Compare TCMD & NRC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TCMD | NRC |
|---|---|---|
| Founded | 1995 | 1981 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Biotechnology: Commercial Physical & Biological Resarch |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 300.1M | 278.8M |
| IPO Year | 2016 | N/A |
| Metric | TCMD | NRC |
|---|---|---|
| Price | $28.15 | $15.94 |
| Analyst Decision | Buy | |
| Analyst Count | 4 | 0 |
| Target Price | ★ $23.25 | N/A |
| AVG Volume (30 Days) | ★ 457.4K | 87.5K |
| Earning Date | 11-03-2025 | 01-26-2026 |
| Dividend Yield | N/A | ★ 4.01% |
| EPS Growth | ★ 18.66 | N/A |
| EPS | ★ 0.77 | 0.71 |
| Revenue | ★ $311,513,000.00 | $139,102,000.00 |
| Revenue This Year | $11.31 | N/A |
| Revenue Next Year | $8.83 | N/A |
| P/E Ratio | $36.20 | ★ $22.35 |
| Revenue Growth | ★ 9.28 | N/A |
| 52 Week Low | $8.61 | $9.76 |
| 52 Week High | $28.04 | $19.71 |
| Indicator | TCMD | NRC |
|---|---|---|
| Relative Strength Index (RSI) | 76.59 | 54.38 |
| Support Level | $24.54 | $15.37 |
| Resistance Level | $28.04 | $16.53 |
| Average True Range (ATR) | 1.06 | 0.74 |
| MACD | -0.05 | -0.23 |
| Stochastic Oscillator | 95.62 | 23.45 |
Tactile Systems Technology Inc is a medical technology company. The company is engaged in developing and providing medical devices for the treatment of chronic diseases. The firm's proprietary platform flexitouch system provides a home-based solution for lymphedema patients. The entire system is another home solution for patients with chronic swelling and actitouch system for chronic venous insufficiency patients that may be worn throughout the day.
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.